IRIS Accounts Production v24.2.0.383 07256153 director 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072561532023-03-31072561532024-03-31072561532023-04-012024-03-31072561532022-08-31072561532022-09-012023-03-31072561532023-03-3107256153ns15:EnglandWales2023-04-012024-03-3107256153ns14:PoundSterling2023-04-012024-03-3107256153ns10:Director12023-04-012024-03-3107256153ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107256153ns10:SmallEntities2023-04-012024-03-3107256153ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107256153ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107256153ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107256153ns10:FullAccounts2023-04-012024-03-310725615312023-04-012024-03-3107256153ns10:RegisteredOffice2023-04-012024-03-3107256153ns5:CurrentFinancialInstruments2024-03-3107256153ns5:CurrentFinancialInstruments2023-03-3107256153ns5:ShareCapital2024-03-3107256153ns5:ShareCapital2023-03-3107256153ns5:FurtherSpecificReserve3ComponentTotalEquity2024-03-3107256153ns5:FurtherSpecificReserve3ComponentTotalEquity2023-03-3107256153ns5:RetainedEarningsAccumulatedLosses2024-03-3107256153ns5:RetainedEarningsAccumulatedLosses2023-03-3107256153ns5:NetGoodwill2023-04-012024-03-3107256153ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107256153ns5:NetGoodwill2023-03-3107256153ns5:NetGoodwill2024-03-3107256153ns5:NetGoodwill2023-03-3107256153ns5:ShortLeaseholdAssetsns5:LandBuildings2023-03-3107256153ns5:FurnitureFittings2023-03-3107256153ns5:ComputerEquipment2023-03-3107256153ns5:ShortLeaseholdAssetsns5:LandBuildings2023-04-012024-03-3107256153ns5:FurnitureFittings2023-04-012024-03-3107256153ns5:ComputerEquipment2023-04-012024-03-3107256153ns5:ShortLeaseholdAssetsns5:LandBuildings2024-03-3107256153ns5:FurnitureFittings2024-03-3107256153ns5:ComputerEquipment2024-03-3107256153ns5:ShortLeaseholdAssetsns5:LandBuildings2023-03-3107256153ns5:FurnitureFittings2023-03-3107256153ns5:ComputerEquipment2023-03-3107256153ns5:ListedExchangeTradedns5:AdditionsToInvestments2024-03-3107256153ns5:DisposalsRepaymentsInvestmentsns5:ListedExchangeTraded2024-03-3107256153ns5:ListedExchangeTradedns5:RevaluationsIncreaseDecreaseInInvestments2024-03-3107256153ns5:ListedExchangeTradedns5:CostValuation2024-03-3107256153ns5:ListedExchangeTraded2024-03-31072561531ns10:Director12023-03-31072561531ns10:Director12022-08-31072561531ns10:Director12023-04-012024-03-31072561531ns10:Director12022-09-012023-03-31072561531ns10:Director12024-03-31072561531ns10:Director12023-03-31
REGISTERED NUMBER: 07256153 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED

COMPANY INFORMATION
for the year ended 31 March 2024







DIRECTOR: Mrs S Bentley





REGISTERED OFFICE: 17 St Peters Place
Fleetwood
Lancashire
FY7 6EB





REGISTERED NUMBER: 07256153 (England and Wales)





ACCOUNTANTS: Jones Harris Limited
17 St Peters Place
Fleetwood
Lancashire
FY7 6EB

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

BALANCE SHEET
31 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 93,778 108,778
Tangible assets 5 3,896 5,194
Investments 6 359,290 -
456,964 113,972

CURRENT ASSETS
Debtors 7 85,518 11,221
Cash at bank 67,092 321,029
152,610 332,250
CREDITORS
Amounts falling due within one year 8 (113,914 ) (120,785 )
NET CURRENT ASSETS 38,696 211,465
TOTAL ASSETS LESS CURRENT
LIABILITIES

495,660

325,437

PROVISIONS FOR LIABILITIES (5,130 ) (1,298 )
NET ASSETS 490,530 324,139

CAPITAL AND RESERVES
Called up share capital 2 2
Fair value reserve 9 12,468 -
Retained earnings 478,060 324,137
490,530 324,139

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 September 2024 and were signed by:





Mrs S Bentley - Director


SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2024

1. STATUTORY INFORMATION

Sarah Barclay Medical Negligence Law Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

2. ACCOUNTING POLICIES - continued

Going concern
The directors are satisfied at the time of approving the financial statements that the company has
adequate resources to continue to operate for the foreseeable future and as such, continues to adopt
the going concern basis in preparing the financial statements.

Listed investments
Investments are measured at fair (current market) value with changes in fair value recognised in the profit and loss.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 300,000
AMORTISATION
At 1 April 2023 191,222
Charge for year 15,000
At 31 March 2024 206,222
NET BOOK VALUE
At 31 March 2024 93,778
At 31 March 2023 108,778

5. TANGIBLE FIXED ASSETS
Fixtures
Short and Computer
leasehold fittings equipment Totals
£    £    £    £   
COST
At 1 April 2023
and 31 March 2024 25,675 17,241 20,207 63,123
DEPRECIATION
At 1 April 2023 25,675 15,318 16,936 57,929
Charge for year - 481 817 1,298
At 31 March 2024 25,675 15,799 17,753 59,227
NET BOOK VALUE
At 31 March 2024 - 1,442 2,454 3,896
At 31 March 2023 - 1,923 3,271 5,194

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

6. FIXED ASSET INVESTMENTS
Listed
investments
£   
COST OR VALUATION
Additions 391,250
Disposals (48,585 )
Revaluations 16,625
At 31 March 2024 359,290
NET BOOK VALUE
At 31 March 2024 359,290

Cost or valuation at 31 March 2024 is represented by:

Listed
investments
£   
Valuation in 2024 16,624
Cost 342,666
359,290

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 342,666 -

Fixed asset investments were valued on an open market basis on 31 March 2024 by Becketts FS Ltd .

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 85,518 11,221

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 377 271
Tax 85,684 67,944
Social security and other taxes 1,635 859
VAT 23,467 48,243
Other creditors 410 337
Directors' current accounts 413 1,528
Accrued expenses 1,928 1,603
113,914 120,785

SARAH BARCLAY MEDICAL NEGLIGENCE LAW
LIMITED (REGISTERED NUMBER: 07256153)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

9. RESERVES
Fair
value
reserve
£   
Transfer 12,468

At 31 March 2024 12,468

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31 March 2024 and the period ended 31 March 2023:

2024 2023
£    £   
Mrs S Bentley
Balance outstanding at start of year - -
Amounts advanced 2,911 -
Amounts repaid (2,911 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

11. RELATED PARTY DISCLOSURES

During the year, total dividends of £72,000 (2023 - £50,000) were paid to the director .